Atlas Trials

HR+/HER2- Locally Advanced, Metastatic Breast Cancer

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HR+/HER2- Locally Advanced, Metastatic Breast Cancer

RecordFirmDate
Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy (NCT06998108)BeBetter Med Inc2022-06-09
UK Ibrance Patient Program (IPP) Study (NCT03921866)Pfizer2019-03-01

Track HR+/HER2- Locally Advanced, Metastatic Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.